Inspiration of the extension of duration of patent right in Japan to new drug research and development in ChinaGU Dong-lei, PAN Xiao-mei, YANG Jing289-294
Research on European supplementary protection certificate and development tendencyLIU Qing, HUANG Chao-feng295-299
Discussion on pharmaceutical characteristics and common problems in manufacturing site inspection of lipid-altering drugsLIU Meng-si, SONG Dan, LIU Jin-xin300-305
Overview of nonclinical safety evaluation methods and techniques for drug-induced neurotoxicityTIAN Kang, QU Zhe, L(U) Jian-jun, WANG Xue, GENG Xing-chao, LI Bo, HUANG Zhi-ying306-311
A survey on cognition about quality control of clinical trial institutionsXIAO Shuang, WANG Yan, ZHU Xue-qi, CHENG Jin-lian312-319
A discussion on the quality evaluation practice of human embryonic stem cells-derived hepatocyte-like cellsNA Tao, SUN Yi, WU Ting-ting, OUYANG Qi, LU Guang-xiu, LIN Ge, YUAN Bao-zhu320-332
Research advance in quality control of protein-based nano-preparationsZHANG Jin-xia, LI Nan, LI Xiao-qin, WANG Qian-wen, DENG Sheng-qi333-338
Research progress in detection of active ingredients in traditional Chinese medicine based on immunoassayZHU Rui-xuan, ZHANG Miao, WANG Peng-qian, HUO Hai-ru, LI Wen-lan, SUI Feng339-346
Research progress on extraction methods and pharmacological effects of eucommia ulmoides polysaccharideZHANG Xiao-fang, HU Wen-zhong, JIANG Ai-li, FENG Ke, HOU Meng-yang347-351
Effect of obeticholic acid on glycolipid homeostasis in type 2 diabetic KKAy miceCAO Hui, HUAN Yi, LI Cai-na, LIU Shuai-nan, LIU Quan, SUN Su-juan, LEI Lei, SHEN Zhu-fang352-356